Plasma-derived medicinal products: demand and clinical use

被引：14
|
作者：
Grazzini, Giuliano [1 ]
Mannucci, Pier Mannuccio [2 ]
Oleari, Fabrizio [3 ]
机构：
[1] Italian Natl Blood Ctr, Natl Inst Hlth, I-00162 Rome, Italy
[2] IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Sci Direct, Milan, Italy
[3] Natl Inst Hlth, Rome, Italy
来源：
BLOOD TRANSFUSION | 2013年 / 11卷
关键词：
ITALIAN DEMAND; POLYVALENT IMMUNOGLOBULINS; PROTHROMBIN COMPLEX; SELF-SUFFICIENCY; FACTOR-VIII; FACTOR-IX; FRACTIONATION; SYSTEM;
D O I：
10.2450/2013.002s
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S2 / S5
页数：4
相关论文
共 50 条
  • [41] Advancing resilience and sustainability in plasma collections and plasma-derived medicinal product accessibility
    van den Hurk, Katja
    VOX SANGUINIS, 2024, 119 (02) : 93 - 93
  • [42] Plasma and plasma-derived medicinal product self-sufficiency: the Italian case
    Calizzani, Gabriele
    Profili, Samantha
    Candura, Fabio
    Lanzoni, Monica
    Vaglio, Stefania
    Cannata, Livia
    Catalano, Liviana
    Chianese, Rosa
    Liumbruno, Giancarlo M.
    Grazzini, Giuliano
    BLOOD TRANSFUSION, 2013, 11 : S118 - S131
  • [43] Manufacturing processes of plasma-derived products remove prions
    Groener, A.
    Schaefer, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 508 - 508
  • [44] Influenzaviruses Are Inactivated by the Manufacturing Process of Plasma-Derived Products
    Groener, Albrecht
    Schaefer, Wolfram
    BLOOD, 2009, 114 (22) : 831 - 831
  • [45] Infusion reactions from human plasma-derived products
    Ko, Hon-Sum
    CLINICAL IMMUNOLOGY, 2007, 123 : S79 - S80
  • [46] Viral safety evaluation of plasma-derived therapeutic products
    Farshid, M
    PDA/EMEA EUROPEAN VIRUS SAFETY FORUM, 2004, 118 : 11 - 15
  • [47] Building a bridge from donors to patients-a review of the journey to personalize the collection of source plasma for plasma-derived medicinal products
    Hartmann, Jan
    Hellman, Eva
    ANNALS OF BLOOD, 2024, 9
  • [48] FDA to propose tracking, notification system for plasma-derived products
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (22) : 2274 - 2274
  • [49] Factor VIII safety: plasma-derived versus recombinant products
    Gringeri, Alessandro
    BLOOD TRANSFUSION, 2011, 9 (04) : 366 - 370
  • [50] Cellular Stress Induced by Plasma-Derived Factor VIII Products
    Brodde, Martin
    Mueller, Anja
    Kehrel, Beate
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (02) : 140 - 144
12345